BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
SillaJen, Inc.
SillaJen, Inc.
Roswell Park Cancer Institute
George Washington University
DualityBio Inc.
Tanabe Pharma America, Inc.
Massive Bio, Inc.
Stanford University
Simcha IL-18, Inc.
Cancer Research UK
Myeloid Therapeutics
Shanghai Yunying Medical Technology